COMET & the clinical course of COVID-19


woensdag, 10/02/2021

The COvid MEdicaTion (COMET) study has grown into one involving more than 4800 patients and 63 hospitals in 10 European countries. Digitalis Rx is proud to contribute to this success with the commitment of Clinical Rules. The first results have been published, including in British Journal of Clinical Pharmacology.

Info: ‘No association between use of ACE inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study’, BJCP, 28 January 2021. Authors: Roos Sablerolles, Freija Hogenhuis, Melvin Lafeber, Bob van de Loo, Sander Borgsteede, Eric Boersma, Jorie Versmissen, Hugo van der Kuy, COMET research team